Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
6.45
-0.31 (-4.59%)
At close: May 9, 2025, 4:00 PM
6.34
-0.11 (-1.71%)
After-hours: May 9, 2025, 6:17 PM EDT
DAWN Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 33.36 | 124.97 | 230.78 | 85.26 | 284.31 | 43.73 | Upgrade
|
| Short-Term Investments | 439.66 | 406.75 | 135.56 | 257.01 | - | - | Upgrade
|
| Cash & Short-Term Investments | 473.02 | 531.72 | 366.35 | 342.27 | 284.31 | 43.73 | Upgrade
|
| Cash Growth | 48.77% | 45.14% | 7.03% | 20.39% | 550.18% | 59.99% | Upgrade
|
| Receivables | 18.05 | 13.88 | - | - | - | - | Upgrade
|
| Inventory | 3.57 | 3.32 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 4.28 | 5.2 | 3.27 | 2.6 | 2.96 | 0.08 | Upgrade
|
| Other Current Assets | 9.73 | 8.22 | 5.66 | 3.01 | 2.1 | 1.26 | Upgrade
|
| Total Current Assets | 508.65 | 562.33 | 375.27 | 347.87 | 289.37 | 45.07 | Upgrade
|
| Property, Plant & Equipment | 5.09 | 4.71 | 0.56 | 0.72 | 0.28 | 0.48 | Upgrade
|
| Other Intangible Assets | 20.41 | 15.63 | - | - | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 0.04 | Upgrade
|
| Other Long-Term Assets | 0.22 | 0.12 | 0.21 | 0.47 | 0.17 | 0.07 | Upgrade
|
| Total Assets | 534.36 | 582.79 | 376.05 | 349.06 | 289.82 | 45.66 | Upgrade
|
| Accounts Payable | 2.54 | 3.26 | 2.58 | 0.26 | 1.74 | 0.2 | Upgrade
|
| Accrued Expenses | 40.58 | 56.46 | 25.48 | 15.77 | 6.61 | 1.57 | Upgrade
|
| Current Portion of Leases | 0.06 | 0.01 | 0.41 | 0.41 | 0.2 | 0.2 | Upgrade
|
| Current Unearned Revenue | 1.64 | 1.55 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 3.07 | 12.16 | 1.04 | 0.18 | 0.1 | 0.03 | Upgrade
|
| Total Current Liabilities | 47.88 | 73.45 | 29.51 | 16.62 | 8.66 | 2 | Upgrade
|
| Long-Term Leases | 2.85 | 2.59 | - | 0.41 | 0.02 | 0.2 | Upgrade
|
| Long-Term Unearned Revenue | 3.35 | 3.23 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.76 | 0.76 | - | - | - | - | Upgrade
|
| Total Liabilities | 54.84 | 80.04 | 29.51 | 17.02 | 8.67 | 2.2 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 2 | Upgrade
|
| Additional Paid-In Capital | 1,070 | 1,057 | 805.11 | 601.77 | 408.63 | - | Upgrade
|
| Retained Earnings | -590.08 | -554.08 | -458.59 | -269.67 | -127.49 | -56.84 | Upgrade
|
| Comprehensive Income & Other | -0.05 | 0.08 | 0.01 | -0.07 | - | 0.64 | Upgrade
|
| Total Common Equity | 479.51 | 502.75 | 346.54 | 332.04 | 281.15 | -54.21 | Upgrade
|
| Minority Interest | - | - | - | - | - | 5.7 | Upgrade
|
| Shareholders' Equity | 479.51 | 502.75 | 346.54 | 332.04 | 281.15 | 43.46 | Upgrade
|
| Total Liabilities & Equity | 534.36 | 582.79 | 376.05 | 349.06 | 289.82 | 45.66 | Upgrade
|
| Total Debt | 2.92 | 2.6 | 0.41 | 0.81 | 0.22 | 0.4 | Upgrade
|
| Net Cash (Debt) | 470.1 | 529.12 | 365.94 | 341.46 | 284.09 | 43.33 | Upgrade
|
| Net Cash Growth | 48.00% | 44.59% | 7.17% | 20.19% | 555.70% | 58.52% | Upgrade
|
| Net Cash Per Share | 4.83 | 5.68 | 4.59 | 5.22 | 7.69 | 7.84 | Upgrade
|
| Filing Date Shares Outstanding | 101.36 | 101.35 | 87.38 | 73.59 | 61.95 | 2.6 | Upgrade
|
| Total Common Shares Outstanding | 101.35 | 101.12 | 87.23 | 73.46 | 61.95 | 2.6 | Upgrade
|
| Working Capital | 460.77 | 488.88 | 345.77 | 331.26 | 280.71 | 43.08 | Upgrade
|
| Book Value Per Share | 4.73 | 4.97 | 3.97 | 4.52 | 4.54 | -20.88 | Upgrade
|
| Tangible Book Value | 459.11 | 487.12 | 346.54 | 332.04 | 281.15 | -54.21 | Upgrade
|
| Tangible Book Value Per Share | 4.53 | 4.82 | 3.97 | 4.52 | 4.54 | -20.88 | Upgrade
|
| Machinery | - | - | - | - | 0.08 | 0.08 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.02 | 0.02 | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.